Every person’s cancer grows in its own way and is unique in terms of the therapies to which it responds. Thus, there is a pressing need for personalized cancer therapies. Dr. Nataly Kravchenko-Balasha’s laboratory at The Hebrew University Faculty of Dental Medicine is analyzing the molecular variations between tumors. By studying inter-tumor heterogeneity, her goal is to help develop tumor-specific smart drug cocktails for fighting cancer.
Dr. Kravchenko-Balasha moved to Israel from the former Soviet Union at the age of 16; she spent four years as a postdoctoral fellow at Caltech, but has always felt that Israel is her home. She remarks, “And the same is true for The Hebrew University, which is not only home, but is also among the best universities in the world, with world-class scientists working together.”